Cargando…

Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis

Alopecia areata (AA) is a type of immune-mediated alopecia. Recent studies have suggested microRNAs’ (miRNAs) implication in several cellular processes, including epidermal and hair follicle biology. Single nucleotide polymorphisms (SNPs) can modify gene expression levels, which may induce an autoim...

Descripción completa

Detalles Bibliográficos
Autores principales: Maher, Shymaa Ahmed, Ismail, Nader Ali, Toraih, Eman A., Habib, Alaa H., Gouda, Nawal S., Gomaa, Amal H. A., Fawzy, Manal S., Helal, Ghada M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138785/
https://www.ncbi.nlm.nih.gov/pubmed/35625530
http://dx.doi.org/10.3390/biom12050602
_version_ 1784714705376378880
author Maher, Shymaa Ahmed
Ismail, Nader Ali
Toraih, Eman A.
Habib, Alaa H.
Gouda, Nawal S.
Gomaa, Amal H. A.
Fawzy, Manal S.
Helal, Ghada M.
author_facet Maher, Shymaa Ahmed
Ismail, Nader Ali
Toraih, Eman A.
Habib, Alaa H.
Gouda, Nawal S.
Gomaa, Amal H. A.
Fawzy, Manal S.
Helal, Ghada M.
author_sort Maher, Shymaa Ahmed
collection PubMed
description Alopecia areata (AA) is a type of immune-mediated alopecia. Recent studies have suggested microRNAs’ (miRNAs) implication in several cellular processes, including epidermal and hair follicle biology. Single nucleotide polymorphisms (SNPs) can modify gene expression levels, which may induce an autoimmune response. This case–control study included 480 participants (240 for each case/control group). MicroRNA-34a gene (MIR-34A) rs2666433A/G variant was genotyped using real-time allelic discrimination polymerase chain reaction (PCR). Additionally, circulatory miR-34a levels were quantified by quantitative reverse transcription PCR (qRT-PCR). On comparing between alopecia and non-alopecia cohorts, a higher frequency of A variant was noted among patients when compared to controls—A allele: 28 versus 18% (p < 0.001); A/A genotype: 9 versus 2%; A/G genotype: 39 versus 32% (p < 0.001). A/A and A/G carriers were more likely to develop alopecia under heterozygote comparison (OR = 1.83, 95% CI = 1.14–2.93), homozygote comparison (OR = 4.19, 95% CI = 1.33–13.1), dominant (OR = 2.0, 95% CI = 1.27–3.15), recessive (OR = 3.36, 95% CI = 1.08–10.48), over-dominant (OR = 1.65, 95% CI = 1.04–32.63), and log additive (OR = 1.91, 95% CI = 1.3–2.82) models. Serum miR-34a expression levels were upregulated in alopecia patients with a median and quartile fold change of 27.3 (1.42–2430). Significantly higher levels were more pronounced in A/A genotype patients (p < 0.01). Patients carrying the heterozygote genotype (rs2666433 * A/G) were two times more likely to develop more severe disease grades. Stratified analysis by sex revealed the same results. A high expression level was associated with concomitant autoimmune comorbidities (p = 0.001), in particular SLE (p = 0.007) and vitiligo (p = 0.049). In conclusion, the MIR34A rs2666433 (A/G) variant is associated with AA risk and severity in the studied population. Furthermore, high miR-34a circulatory levels could play a role in disease pathogenesis.
format Online
Article
Text
id pubmed-9138785
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91387852022-05-28 Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis Maher, Shymaa Ahmed Ismail, Nader Ali Toraih, Eman A. Habib, Alaa H. Gouda, Nawal S. Gomaa, Amal H. A. Fawzy, Manal S. Helal, Ghada M. Biomolecules Article Alopecia areata (AA) is a type of immune-mediated alopecia. Recent studies have suggested microRNAs’ (miRNAs) implication in several cellular processes, including epidermal and hair follicle biology. Single nucleotide polymorphisms (SNPs) can modify gene expression levels, which may induce an autoimmune response. This case–control study included 480 participants (240 for each case/control group). MicroRNA-34a gene (MIR-34A) rs2666433A/G variant was genotyped using real-time allelic discrimination polymerase chain reaction (PCR). Additionally, circulatory miR-34a levels were quantified by quantitative reverse transcription PCR (qRT-PCR). On comparing between alopecia and non-alopecia cohorts, a higher frequency of A variant was noted among patients when compared to controls—A allele: 28 versus 18% (p < 0.001); A/A genotype: 9 versus 2%; A/G genotype: 39 versus 32% (p < 0.001). A/A and A/G carriers were more likely to develop alopecia under heterozygote comparison (OR = 1.83, 95% CI = 1.14–2.93), homozygote comparison (OR = 4.19, 95% CI = 1.33–13.1), dominant (OR = 2.0, 95% CI = 1.27–3.15), recessive (OR = 3.36, 95% CI = 1.08–10.48), over-dominant (OR = 1.65, 95% CI = 1.04–32.63), and log additive (OR = 1.91, 95% CI = 1.3–2.82) models. Serum miR-34a expression levels were upregulated in alopecia patients with a median and quartile fold change of 27.3 (1.42–2430). Significantly higher levels were more pronounced in A/A genotype patients (p < 0.01). Patients carrying the heterozygote genotype (rs2666433 * A/G) were two times more likely to develop more severe disease grades. Stratified analysis by sex revealed the same results. A high expression level was associated with concomitant autoimmune comorbidities (p = 0.001), in particular SLE (p = 0.007) and vitiligo (p = 0.049). In conclusion, the MIR34A rs2666433 (A/G) variant is associated with AA risk and severity in the studied population. Furthermore, high miR-34a circulatory levels could play a role in disease pathogenesis. MDPI 2022-04-19 /pmc/articles/PMC9138785/ /pubmed/35625530 http://dx.doi.org/10.3390/biom12050602 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maher, Shymaa Ahmed
Ismail, Nader Ali
Toraih, Eman A.
Habib, Alaa H.
Gouda, Nawal S.
Gomaa, Amal H. A.
Fawzy, Manal S.
Helal, Ghada M.
Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
title Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
title_full Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
title_fullStr Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
title_full_unstemmed Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
title_short Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
title_sort hair follicle-related microrna-34a serum expression and rs2666433a/g variant in patients with alopecia: a cross-sectional analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138785/
https://www.ncbi.nlm.nih.gov/pubmed/35625530
http://dx.doi.org/10.3390/biom12050602
work_keys_str_mv AT mahershymaaahmed hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT ismailnaderali hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT toraihemana hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT habibalaah hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT goudanawals hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT gomaaamalha hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT fawzymanals hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis
AT helalghadam hairfolliclerelatedmicrorna34aserumexpressionandrs2666433agvariantinpatientswithalopeciaacrosssectionalanalysis